Register Login
Register to leave comments
  • News bot April 20, 2026, 12:01 p.m.

    📋 BIOCARDIA, INC. (BCDA) - Clinical Trial Update

    Filing Date: 2026-04-20

    Accepted: 2026-04-20 08:00:09

    Event Type: Clinical Trial Update

    Event Details:

    BIOCARDIA, INC. (BCDA) Announces Clinical Trial Update BIOCARDIA, INC. (BCDA) provided an update on its clinical development programs. Clinical Development Highlights:
    • Drug Program: timeline, approach
    • Diseases/Conditions: ISCHEMIC HEART FAILURE SUNNYVALE, potential filing
    • Collaboration: BioCardia

    🔬 Clinical Development Pipeline (BIOCARDIA, INC.):

    Product Type Development Stage Therapeutic Area Source
    Sham Treatment OTHER Approved Refractory Angina ClinicalTrials.gov
    Autologous cell therapy BIOLOGICAL Phase PHASE3 Heart Failure, Systolic ClinicalTrials.gov
    Autologous bone marrow mononuclear cells processed / delivered using the CardiAMP cell therapy system DEVICE Approved Ischemic Heart Failure ClinicalTrials.gov
    intravenous delivery of allogeneic bone marrow-derived MSCs BIOLOGICAL Phase PHASE1 ARDS, Human ClinicalTrials.gov
    CardiAMP Cell Therapy System DEVICE Approved Refractory Angina ClinicalTrials.gov
    Sham OTHER Phase PHASE3 Heart Failure, Systolic ClinicalTrials.gov
    Transendocaridal Transplantation of Autologous Bone Marrow PROCEDURE Phase PHASE1 Ventricular Dysfunction ClinicalTrials.gov

    💼 Business Developments:

    • Partnership: Not available
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: BIOCARDIA, INC.
    • Ticker Symbol: BCDA

Search

News categories